StonvexLoading…
StonvexStonvexStonvexCore line items from CBOE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-30 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $704.26M | $1.27B | $4.71B | $3.51B | $2.37B |
Operating Income | Not available | $505.60M | $1.47B | $1.06B | $693.00M |
Net Income | Not available | $385.70M | $1.10B | $786.50M | $485.70M |
EPS (Diluted) | $3.38 | $3.66 | $10.42 | $7.45 | $4.60 |
Total Assets | Not available | $11.07B | $9.31B | $9.07B | $9.05B |
Total Liabilities | Not available | $5.70B | $4.17B | $4.18B | $4.38B |
Cash & Equivalents | Not available | $2.13B | $2.22B | $1.50B | $1.26B |
Free Cash Flow OCF − CapEx | Not available | $1.94B | $1.68B | $1.35B | $1.21B |
Shares Outstanding | Not available | 104.67M | 104.65M | 104.64M | 104.59M |